openPR Logo
Press release

Colorectal Cancer Diagnostics Market To Surpass A Valuation of US$ 2,000 Mn Over 2022

08-30-2017 07:56 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Colorectal Cancer Diagnostics Market To Surpass A Valuation

The global colorectal cancer diagnostics market is anticipated to exhibit an impressive expansion at a CAGR of 8.5% during the forecast period 2017 to 2022, according to a report by Fact.MR. Global revenues from the market is projected to surpass US$ 2,000 Mn by 2022-end.

According to the World Cancer Research Fund, colorectal cancer forms the third-most occurring type of cancer across the globe. In 2012, over 1 Mn cases of colorectal cancer were diagnosed. Majority of these cases were reported across developed economies, and this is further estimated to exceed in the near future. This rise in incidences of colorectal cancer has boosted demand for its diagnostics, treatment, and therapeutics worldwide. However, the number of deaths owing to colorectal cancer has been witnessing a decline since recent past, owing to the awareness spread by the American Cancer Society. The introduction of more effective diagnostics, and development of screening methods are further expected to drive growth of the global colorectal cancer diagnostics market.

For More Details - A sample of this report is available upon request@ https://www.factmr.com/connectus/sample?flag=S&rep_id=70

The advent of new diagnostic tests, increasing uptakes of diagnosis-associated therapies, and initiatives taken by private as well as government organisations are some factors expected to propel growth of the global market for colorectal cancer diagnostics. Increasing unmet requirements across several emerging economies, coupled with the absence of neoadjuvant and adjuvant pipeline agents for diagnosing high-risk patients affected with resectable colorectal cancer is expected to create huge growth opportunities for leading players in the market. However, factors such as growing reluctance towards medications of colorectal cancer by patients, and unawareness across several remote regions of the globe is expected to inhibit the market growth.

6 Key Projections for the Global Colorectal Cancer Diagnostics Market

North America will continue to be the most lucrative region for the colorectal cancer diagnostics market. Revenue from market in North America is expected to surpass US$ 800 Mn by 2022-end.

The colorectal cancer diagnostics market in Asia Pacific excluding Japan (APEJ) is expected to register the fastest expansion during the forecast period. However, revenue from the market in Middle East & Africa (MEA) will continue to be sluggish during the forecast period.

By test type, FOB will continue to be the largest adopted test for diagnosis of colorectal cancer across the globe. Revenue from FOB tests for colorectal cancer diagnostics will remain largest, followed by CTC tests.

Request For Report Discount: https://www.factmr.com/connectus/sample?flag=D&rep_id=70

Immunochemistry tests for colorectal cancer diagnostics will exhibit the highest CAGR through 2022. However, revenue from BRAF tests will remain the lowest in the global colorectal cancer diagnostics market during the forecast period.

On the basis of end-users, although hospital-associated labs will remain sought-after in the market, cancer research institutes will continue to register the fastest expansion during the forecast period.

Revenues from hospital-associated labs for colorectal cancer diagnostics are expected to reach nearly US$ 1,000 Mn by 2022-end. Independent diagnostic laboratories will continue to be the second most lucrative end-users in the global colorectal cancer diagnostics market.

The report also includes a comprehensive landscape of global market for colorectal cancer diagnostics, where companies namely Illumina, Inc., Foundation Medicine, Inc., Sysmex Corporation, Cancer Genetics, Inc., Danaher Corporation, Biocept, Inc, Pathway Genomics Corporation, Rosetta Genomics, Epigenomics AG, and Exact Science Corporation are profiled.

Browse Full Report: https://www.factmr.com/report/70/colorectal-cancer-diagnostics-market

ABOUT US:
Fact.MR is focused on offering transformative intelligence that inspires breakthroughs and innovation. We believe that the right decisions at the opportune time are integral to achieve extraordinary success. We are here to help you with your strategic decision making.

CONTACT:
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Phone: +353-1-6111-593
Email: sales@factmr.com
Website: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Colorectal Cancer Diagnostics Market To Surpass A Valuation of US$ 2,000 Mn Over 2022 here

News-ID: 690215 • Views: โ€ฆ

More Releases from Fact.MR

E-Compass Market $11.9 Billion Discovery By 2033 | Fact.MR
E-Compass Market $11.9 Billion Discovery By 2033 | Fact.MR
In 2023, the global E-Compass Market reached a valuation of US$ 2.6 billion, and projections indicate a substantial growth trajectory, with estimates soaring to US$ 11.9 billion by 2033. ๐—š๐—ฒ๐˜ ๐—™๐—ฟ๐—ฒ๐—ฒ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—–๐—ผ๐—ฝ๐˜†: https://www.factmr.com/connectus/sample?flag=S&rep_id=8417 This remarkable surge in market value is attributed to the anticipated surge in worldwide electronic compass sales, expected to surge at an impressive Compound Annual Growth Rate (CAGR) of 16.5% over the coming decade. The eCompass, an electricโ€ฆ
Drone Delivery Service Market Set for US$ 3,090.5 Million by 2033
Drone Delivery Service Market Set for US$ 3,090.5 Million by 2033
The global Drone Delivery Service Market surged to a valuation of US$ 359.6 million, with projections soaring to US$ 3,090.5 million by 2033. This impressive growth, marked by a robust Compound Annual Growth Rate (CAGR) of 24.0% from 2023 to 2033, highlights the burgeoning potential of drone delivery services on a global scale. ๐—š๐—ฒ๐˜ ๐—™๐—ฟ๐—ฒ๐—ฒ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—–๐—ผ๐—ฝ๐˜†: https://www.factmr.com/connectus/sample?flag=S&rep_id=8127 Initially comprising 5% of the overall drone service market at a value ofโ€ฆ
Patient Lifting Equipment Market Set to Surpass US$ 2.3 Billion by 2027
03-28-2024 | Health & Medicine
Fact.MR
Patient Lifting Equipment Market Set to Surpass US$ 2.3 Billion by 2027
The global demand for Patient Lifting Equipment is projected to surge with a robust compound annual growth rate (CAGR) of 7.3% from 2022 to 2027. Presently valued at US$ 1.5 billion, the global market for patient lifting equipment is forecasted to escalate to US$ 2.3 billion by the conclusion of 2027. ๐—š๐—ฒ๐˜ ๐—™๐—ฟ๐—ฒ๐—ฒ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—–๐—ผ๐—ฝ๐˜†: https://www.factmr.com/connectus/sample?flag=S&rep_id=7566 Factors such as a rising incidence of accidents leading to significant injuries and a growingโ€ฆ
Thermoplastic Polyurethane Market on Track to Hit US$ 5.8 Billion by 2032
Thermoplastic Polyurethane Market on Track to Hit US$ 5.8 Billion by 2032
The global sales of the Thermoplastic Polyurethane Market amounted to US$ 3 billion. Forecasted with a Compound Annual Growth Rate (CAGR) of 6% from 2022 to 2032, the market is anticipated to soar to US$ 5.8 billion by the conclusion of 2032. Among the various segments, Polyester-Type Thermoplastic Polyurethanes is poised to lead in revenue generation, with a projected CAGR exceeding 7% during the period of 2022 to 2032. According toโ€ฆ

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by โ€ฆ
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emergingโ€ฆ
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio โ€ฆ
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boostโ€ฆ
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p โ€ฆ
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strengthโ€ฆ
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve โ€ฆ
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:โ€ฆ
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance โ€ฆ
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launchโ€ฆ
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C โ€ฆ
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on topโ€ฆ